Evidence map›Paper›PMID 41291012›Full record

ArticleCommunications biology2025

The HUSH complex facilitates the exit of pluripotency.

Bowen Wang, Min Qi, Yanqi Sun, Huaqi Liao, Yuzhuo Xu, Lixia Dong, Lijun Xu, Yin Xia, Xiaochun Jiang, Shizhang Ling and 1 more

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bowen Wang *State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animals for Disease Study, Model Animal Research Center, Medical School of Nanjing University, Nanjing, China.ORCID http://orcid.org/0009-0009-4025-3129
Min Qi *State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animals for Disease Study, Model Animal Research Center, Medical School of Nanjing University, Nanjing, China.ORCID http://orcid.org/0009-0001-4071-7079
Yanqi SunState Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animals for Disease Study, Model Animal Research Center, Medical School of Nanjing University, Nanjing, China.
Huaqi LiaoState Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animals for Disease Study, Model Animal Research Center, Medical School of Nanjing University, Nanjing, China.ORCID http://orcid.org/0000-0001-5217-4940
Yuzhuo XuState Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animals for Disease Study, Model Animal Research Center, Medical School of Nanjing University, Nanjing, China.ORCID http://orcid.org/0009-0008-9644-3813
Lixia DongState Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animals for Disease Study, Model Animal Research Center, Medical School of Nanjing University, Nanjing, China.ORCID http://orcid.org/0000-0003-0199-6949
Lijun XuState Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animals for Disease Study, Model Animal Research Center, Medical School of Nanjing University, Nanjing, China.ORCID http://orcid.org/0000-0003-0537-3239
Yin XiaSchool of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China.ORCID http://orcid.org/0000-0003-0315-7532
Xiaochun JiangThe Translational Research Institute for Neurological Disorders, Department of Neurosurgery, the First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Anhui, Wuhu, China. jiangxiaochun2001@hotmail.com.ORCID http://orcid.org/0000-0003-0246-1292
Shizhang LingThe Translational Research Institute for Neurological Disorders, Department of Neurosurgery, the First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Anhui, Wuhu, China. sling@wnmc.edu.cn.ORCID http://orcid.org/0000-0002-6856-3577
Jinzhong QinState Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animals for Disease Study, Model Animal Research Center, Medical School of Nanjing University, Nanjing, China. qinjz@nju.edu.cn.ORCID http://orcid.org/0000-0001-9583-1488

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human silencing hub (HUSH) maintains the genome integrity by silencing invasive genetic elements. However, despite essential roles of the HUSH complex during early embryonic development, the function of the complex in the maintenance of pluripotency is mostly unknown. Here, using CRISPR-based genome editing, we demonstrate that in mouse embryonic stem cells (mESCs), deficiency of HUSH core members MPP8 or TASOR, but not PPHLN1, triggers alteration of colony morphology, and mild defect in exit from pluripotency. Importantly, Mpp8/Tasor double mutants are locked in pluripotent state even upon differentiation stimuli. We further demonstrate that these phenotypes are accompanied by decreased expression of adhesion-related genes. Strikingly, the abnormalities observed in Mpp8/Tasor-null mESCs were largely rescued by ectopic coexpression of cell-adhesion associated genes keratins 18 and 19. Thus, our study provides new insights into the mechanisms by which the HUSH complex coordinates the exit from pluripotency through regulation of the cell adhesion machinery.

Indexed as

Mouse Embryonic Stem CellsPluripotent Stem CellsAnimalsCell AdhesionCell DifferentiationHumansMice

Identifiers

PMID41291012
PMCPMC12647722

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.